
Michelle Alyssa Tran, PhD
@michelle_a_tran
MD/PhD Student @BhardwajLab @IcahnMountSinai | Founder @SoarOverHate 501(c)(3) | @lorealparisusa Woman of Worth | @IUIS_online Social Media Lead
ID: 1395557515
http://www.soaroverhate.org 01-05-2013 20:47:14
1,1K Tweet
1,1K Followers
944 Following


📜#INFLAMMAGING STUDY📜Aging is the main risk factor for cancer. In Science Magazine, Matthew D. Park, Ph.D. & Miriam Merad, MD, PhD describe how an aging hematopoietic system fuels myeloid dysfunction and inhibits control of lung tumors, raising new treatment options 👇 science.org/doi/10.1126/sc…

Thrilled to share our first study on aging from Miriam Merad, MD, PhD lab Icahn School of Medicine at Mount Sinai The Tisch Cancer Institute Lipschultz Precision Immunology Institute in which we demonstrate how aging promotes cancer. We show that: (1/n) science.org/doi/10.1126/sc…

Excited and honored to co-lead our newly-established Center of Excellence for Gynecologic Cancer Mount Sinai Health System with the amazing Stephanie Blank.

🎉Congratulations🥳 Bhardwaj Lab Dr. Nina Bhardwaj, elected to National Academy of Medicine for advancing our understanding of human dendritic cell cross-presentation pathways and adjuvanticity, ‘pivotal discoveries which underlie the first approval of a cell-based vaccine in cancer.’

Congratulations to my incredible PI, Bhardwaj Lab Dr. Nina Bhardwaj, on being elected to National Academy of Medicine! It's an honor to learn from you!

Celebrating our PI Dr. Nina Bhardwaj! What an amazing week; elected to the National Academy of Medicine on Monday, then selected as Inventor of the Year (Mount Sinai Innovation Awards)…we are all so proud to be in your lab! Cheers 🥂!



I'm very excited to share that I have been named one of Forbes Forbes Under 30 in Healthcare for my work on cancer and aging. It's an overwhelming honor to be recognized this way, thanks to the support of Miriam Merad, MD, PhD Lipschultz Precision Immunology Institute Icahn School of Medicine at Mount Sinai The Tisch Cancer Institute #ForbesUnder30


.@EmilyAshkin et al Monte Winslow's Lab underscore important roles of STAG2 in suppressing lung tumorigenesis & highlight a STAG2-PAXIP1/PAGR1 tumor-suppressive program that may transcend cancer type. hubs.la/Q02-Y7_D0 Haiqing Xu King L Hung Howard Chang Jesse Dixon Zhichao Xu 徐志超


Does the gut #microbiome predispose patients to immunotherapy-related colitis? Our study in Journal of Experimental Medicine explores the #microbiota before, during, and after #colitis induced by #cancer #immunotherapy in a prospective cohort. Read here: hubs.la/Q02_r1nl0 #MedTwitter #GITwitter

What Happens When Some Cells Are More Dad Than Mom (and Vice Versa)? Latest from us. Published today. News here cuimc.columbia.edu/news/what-happ… article here: nature.com/articles/s4158… O'Jay Stewart BogunovicLab and a huge international team thank you 🙏🏼 Columbia Children's Health Lipschultz Precision Immunology Institute

💸💰💵💲 The cost of treating #bladdercancer is astounding 👇Check out the latest review in European Urology "The Financial Burden of Localized and Metastatic Bladder Cancer"📉 🔗tinyurl.com/22wfuc8w Shilpa Gupta Alicia Morgans, MD, MPH Roger Li Marco Moschini Peter Black Andrea Necchi


Congratulations to one of my mentors, Matt Galsky !

Congratulations to Ashley Reid Cahn (Ashley Reid), co-mentored by Dr. Nina Bhardwaj and Nicolas Vabret, on successfully defending her PhD this past Friday! We are excited for you and look forward to following your career in the future.


Honored to receive Mike Slive Foundation award for our efforts towards an off-the-shelf prostate cancer vaccine. Special thanks to my rockstar colleagues for laying all the pioneering innovative foundation Tim O'Donnell Julia Kodysh Cansu Cimen Bozkus Mansi Saxena Bhardwaj Lab



Devastating to hear of a child's death from measles—a completely preventable disease. Even more concerning is public health officials downplaying the outbreak. attached is an important article on the lifesaving impact of measles vaccines. #FollowTheData academic.oup.com/jid/article/22…

PGV001, a multi-peptide personalized neoantigen vaccine platform: Phase I study in patients with solid and hematological malignancies in the adjuvant setting aacrjournals.org/cancerdiscover… Bhardwaj Lab Thomas Marron, MD, PhD Icahn School of Medicine at Mount Sinai

